included 05-1341 (anti-H3K4unmod), 05-745R
(anti-H3K4me3), ABE18 (H3K9Ac), 07-452 (K3K27me2), and 07-449 (HeK27me3).
Figure 3. Reduction in ChIP variability using the AccuChIP spike in reagent. The AccuChIP
874 (2000).
4. Chen, H. et al., J. Cell Biol., 160, 189-200 (2003).
5. Bach, D. et al., J. Biol. Chem., 278, 17190-17197
(2003).
6. Zuchner, S. et al., Nature Genet., 36, 449-51 (2004).
250 g
$449
$906
OmniPur® Agarose, Low Melting 2070 100 g $629
OmniPur® Agarose, High Gel Strength 2090 100 g $246
OmniPur® Ethyl Alcohol, Pure, 200 Proof 4450
4455
500 ml
4 l
$30
Weller, A., et al., J. Cell Biol., 112, 355 (1991).
9. Castelluci, M., et al., Histochemistry, 95, 449
(1991).
10. Balza, E., et al., FEBS Lett., 332, 39 (1993).
*Due to the sodium azide content
Borsi, L. et al., Int. J. Cancer, 52 688-92 (1992).
11. Castellucci, M. et al., Histochemistry, 95, 449-58
(1991).
12. Balza, E. et al., FEBS Lett., 332, 39-43 (1993).
13. Lotz, MM. et al., J. Cell
Opin.
Neurobiol., 7, 346 (1997).
8. Afework, M. and Burnstock, G., Cell Tissue Res.,
298, 449 (1999).
9. Hansen, M.A. et al., J. Auton. Nerv. Syst., 78, 1
(1999).
10. Kanijan, R. et al., J.
Curr. Opin.
Neurobiol., 7, 346 (1997).
7. Afework, M. and Burnstock, G., Cell Tissue Res.,
298, 449 (1999).
8. Hansen, M.A. et al., J. Auton. Nerv. Syst., 78, 1
(1999).
9. Kanijan, R. et al.
D.B. and Fryer, A.D., Clin. Exp. Allergy, 29,
59 (1999).
16. Fryer, A.D. et al., Life Sci., 64, 449 (1999).
17. Retondaro, F.C. et al., FASEB J., 13, 2015 (1999).
18. Matsui, S. et al., J. Card.
Dentin, R. et al., Insulin modulates
gluconeogenesis by inhibition of the coactivator
TORC2. Nature, 449, 366-369 (2007).
PRECISIO is a registered trademark of Sigma-Aldrich
Co. LLC.
TD,MAM 11/11-1
non-specific staining with
the conjugated second antibody.
References
Jones, N., et al., Leuk. Res., 6, 449 (1982).
Clark, E.A., and Yokochi, T., In: Leucocyte Typing II (ed.
E.L. Reinherz, et al.) 2, 339 (1986
.B. and Fryer, A.D., Clin. Exp. Allergy, 29,
59 (1999).
16. Fryer, A.D. et al., Life Sci., 64, 449 (1999).
17. Retondaro, F.C. et al., FASEB J., 13, 2015 (1999).
18. Matsui, S. et al., J. Card. Fail
leukemic cells.
3. Platelet activation studies.
4. Purification of CD9 antigen.
Reagents
The product is provided as purified antibody
(200 µg/ml) in 0.01 M phosphate buffered saline,
pH 7.4
1x PB with a 1/200 volume of the 200 mM GTP to obtain
1mM final GTP concentration in 1xPB.
• Keeping reagents on ice, dilute 240 µM tubulin stock solution with 1x PB-GTP solution 4-
fold to obtain
resistin-like molecules in the
inflammatory process and insulin resistance. Curr.
Diabetes Rev., 2(4), 449-54 (2006).
2. Miner, J.L., The adipocyte as an endocrine cell. J.
Anim. Sci., 82(3), 935-41
microscope.
15. Using modified P-200 tips (from step 2), pipette 1-4 organoids into each well of an 8-well chamber slide.
Remove any residual PBS using an unmodified P-200 pipette tip. Avoid accidentally